NH NongwoobioNH농우바이오

NH Nongwoobio shows steady trailing profits and a low valuation, but its share price has fallen about 20% over the past year.

NH Nongwoobio is a Korean vegetable seed and agricultural materials developer with overseas subsidiaries in about seven countries. Trailing twelve-month revenue to H1 2026 is ₩160.5B with operating income of ₩10.7B and net income of ₩19.3B, while the shares closed at ₩6,800, near the lower half of their 52-week range. Its filings in September and October 2026 include a business acquisition decision, a trading halt and a notice of a shareholders' meeting.

What stands out

• Revenue grew 9.8% in 2025 to ₩158.8B, but operating income fell from 2024 levels to ₩13.6B in 2025 and trailing operating income is lower at ₩10.7B, so margins are tighter than the 2025 peak.
• Trailing net income of ₩19.3B is well above trailing operating income, a gap the data does not explain.
• Valuation metrics are low: P/E of 5.6, P/B of 0.4, and a 3.7% dividend yield, compared with a DCF base value of ₩10,160 and a bear-to-bull range of ₩6,298 to ₩16,995.
• Foreign ownership fell from 2.5% to 1.5% over 60 days, and foreign investors were net sellers over the past 20 days, while retail investors were net buyers.
• Recent filings center on a business acquisition decision (September 29, with an amendment on October 1), but the data does not say what business is being acquired or its size.

What to watch

• Details and completion status of the business acquisition, including the amended attachment filed October 1, 2026.
• Outcome of the shareholders' meeting noticed on October 22, 2026, including any dividend or agenda items, which the data does not specify.
• Whether operating margin recovers from the 6.7% trailing level toward the 8.6% seen in 2025.